{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T13:33:11Z","timestamp":1776691991535,"version":"3.51.2"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T00:00:00Z","timestamp":1541980800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007394","name":"Association Laurette Fugain","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007394","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Nationale contre le Cancer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"crossref"}]},{"name":"SIRIC BRIO"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4993-2","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T08:11:17Z","timestamp":1542010277000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms"],"prefix":"10.1186","volume":"18","author":[{"given":"Pierre-Yves","family":"Dumas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Mansier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Prouzet-Mauleon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Koya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Villacreces","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Brunet de la Grange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Luque Paz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Bidet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Max","family":"Pasquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Praloran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franck","family":"Salin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mineo","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois-Xavier","family":"Mahon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Cardinaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Lippert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,12]]},"reference":[{"key":"4993_CR1","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa1214514","volume":"368","author":"JE Maxson","year":"2013","unstructured":"Maxson JE, Gotlib J, Pollyea DA, Fleischman AG, Agarwal A, Eide CA, et al. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med. 2013;368:1781\u201390. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1214514\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"4993_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ng.2495","volume":"45","author":"R Piazza","year":"2013","unstructured":"Piazza R, Valletta S, Winkelmann N, Redaelli S, Spinelli R, Pirola A, et al. Recurrent SETBP1 mutations in atypical chronic myeloid leukemia. Nat Genet. 2013;45:18\u201324. \n                    https:\/\/doi.org\/10.1038\/ng.2495\n                    \n                  .","journal-title":"Nat Genet"},{"key":"4993_CR3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrm2868","volume":"11","author":"M Inui","year":"2010","unstructured":"Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol. 2010;11:252\u201363. \n                    https:\/\/doi.org\/10.1038\/nrm2868\n                    \n                  .","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4993_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0896-6273(00)80513-9","volume":"21","author":"A Gould","year":"1998","unstructured":"Gould A, Itasaki N, Krumlauf R. Initiation of rhombomeric Hoxb4 expression requires induction by somites and a retinoid pathway. Neuron. 1998;21:39\u201351.","journal-title":"Neuron"},{"key":"4993_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/bies.20704","volume":"30","author":"A Lempradl","year":"2008","unstructured":"Lempradl A, Ringrose L. How does noncoding transcription regulate Hox genes? BioEssays News Rev Mol Cell Dev Biol. 2008;30:110\u201321. \n                    https:\/\/doi.org\/10.1002\/bies.20704\n                    \n                  .","journal-title":"BioEssays News Rev Mol Cell Dev Biol"},{"key":"4993_CR6","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/ng1421","volume":"36","author":"JH Mansfield","year":"2004","unstructured":"Mansfield JH, Harfe BD, Nissen R, Obenauer J, Srineel J, Chaudhuri A, et al. MicroRNA-responsive \u201csensor\u201d transgenes uncover Hox-like and other developmentally regulated patterns of vertebrate microRNA expression. Nat Genet. 2004;36:1079\u201383. \n                    https:\/\/doi.org\/10.1038\/ng1421\n                    \n                  .","journal-title":"Nat Genet"},{"key":"4993_CR7","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.3324\/haematol.2010.023481","volume":"95","author":"D Schotte","year":"2010","unstructured":"Schotte D, Lange-Turenhout EAM, Stumpel DJPM, Stam RW, Buijs-Gladdines JGCAM, Meijerink JPP, et al. Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia. Haematologica. 2010;95:1675\u201382. \n                    https:\/\/doi.org\/10.3324\/haematol.2010.023481\n                    \n                  .","journal-title":"Haematologica"},{"key":"4993_CR8","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.1073\/pnas.0600587103","volume":"103","author":"R Garzon","year":"2006","unstructured":"Garzon R, Pichiorri F, Palumbo T, Iuliano R, Cimmino A, Aqeilan R, et al. MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci U S A. 2006;103:5078\u201383. \n                    https:\/\/doi.org\/10.1073\/pnas.0600587103\n                    \n                  .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4993_CR9","first-page":"1284","volume":"6","author":"L Han","year":"2007","unstructured":"Han L, Witmer PD, Casey E, Valle D, Sukumar S. DNA methylation regulates MicroRNA expression. Cancer Biol Ther. 2007;6:1284\u20138.","journal-title":"Cancer Biol Ther"},{"key":"4993_CR10","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1053\/j.gastro.2009.08.065","volume":"137","author":"FU Weiss","year":"2009","unstructured":"Weiss FU, Marques IJ, Woltering JM, Vlecken DH, Aghdassi A, Partecke LI, et al. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. Gastroenterology. 2009;137:2136\u20132145.e7. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2009.08.065\n                    \n                  .","journal-title":"Gastroenterology"},{"key":"4993_CR11","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1158\/1541-7786.MCR-08-0167","volume":"6","author":"X Agirre","year":"2008","unstructured":"Agirre X, Jim\u00e9nez-Velasco A, San Jos\u00e9-En\u00e9riz E, Garate L, Bandr\u00e9s E, Cordeu L, et al. Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. Mol Cancer Res MCR. 2008;6:1830\u201340. \n                    https:\/\/doi.org\/10.1158\/1541-7786.MCR-08-0167\n                    \n                  .","journal-title":"Mol Cancer Res MCR"},{"key":"4993_CR12","doi-asserted-by":"publisher","first-page":"9383","DOI":"10.1074\/jbc.M109.095612","volume":"285","author":"H Huang","year":"2010","unstructured":"Huang H, Xie C, Sun X, Ritchie RP, Zhang J, Chen YE. miR-10a contributes to retinoid acid-induced smooth muscle cell differentiation. J Biol Chem. 2010;285:9383\u20139. \n                    https:\/\/doi.org\/10.1074\/jbc.M109.095612\n                    \n                  .","journal-title":"J Biol Chem"},{"key":"4993_CR13","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1074\/jbc.M110.167817","volume":"286","author":"S Meseguer","year":"2010","unstructured":"Meseguer S, Mudduluru G, Escamilla JM, Allgayer H, Barettino D. MicroRNAs-10a and -10b contribute to retinoic acid-induced differentiation of neuroblastoma cells and target the alternative splicing regulatory factor SFRS1 (SF2\/ASF). J Biol Chem. 2010;286:4150\u201364. \n                    https:\/\/doi.org\/10.1074\/jbc.M110.167817\n                    \n                  .","journal-title":"J Biol Chem"},{"key":"4993_CR14","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/cdd.2010.172","volume":"18","author":"NH Foley","year":"2011","unstructured":"Foley NH, Bray I, Watters KM, Das S, Bryan K, Bernas T, et al. MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2. Cell Death Differ. 2011;18:1089\u201398. \n                    https:\/\/doi.org\/10.1038\/cdd.2010.172\n                    \n                  .","journal-title":"Cell Death Differ"},{"key":"4993_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1479-5876-6-39","volume":"6","author":"P Jin","year":"2008","unstructured":"Jin P, Wang E, Ren J, Childs R, Shin J, Khuu H, et al. Differentiation of two types of mobilized peripheral blood stem cells by microRNA and cDNA expression analysis. J Transl Med. 2008;6:39. \n                    https:\/\/doi.org\/10.1186\/1479-5876-6-39\n                    \n                  .","journal-title":"J Transl Med"},{"key":"4993_CR16","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1073\/pnas.0800135105","volume":"105","author":"R Garzon","year":"2008","unstructured":"Garzon R, Garofalo M, Martelli MP, Briesewitz R, Wang L, Fernandez-Cymering C, et al. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci U S A. 2008;105:3945\u201350. \n                    https:\/\/doi.org\/10.1073\/pnas.0800135105\n                    \n                  .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4993_CR17","doi-asserted-by":"publisher","first-page":"1708.e1","DOI":"10.1016\/j.exphem.2007.08.020","volume":"35","author":"P Guglielmelli","year":"2007","unstructured":"Guglielmelli P, Tozzi L, Pancrazzi A, Bogani C, Antonioli E, Ponziani V, et al. MicroRNA expression profile in granulocytes from primary myelofibrosis patients. Exp Hematol. 2007;35:1708.e1\u20131708.e12. \n                    https:\/\/doi.org\/10.1016\/j.exphem.2007.08.020\n                    \n                  .","journal-title":"Exp Hematol"},{"key":"4993_CR18","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1182\/blood-2010-09-191312","volume":"117","author":"G Marcucci","year":"2011","unstructured":"Marcucci G, Mr\u00f3zek K, Radmacher MD, Garzon R, Bloomfield CD. The prognostic and functional role of microRNAs in acute myeloid leukemia. Blood. 2011;117:1121\u20139. \n                    https:\/\/doi.org\/10.1182\/blood-2010-09-191312\n                    \n                  .","journal-title":"Blood"},{"key":"4993_CR19","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.exphem.2011.07.008","volume":"39","author":"D Ovcharenko","year":"2011","unstructured":"Ovcharenko D, St\u00f6lzel F, Poitz D, Fierro F, Schaich M, Neubauer A, et al. miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia. Exp Hematol. 2011;39:1030\u20131042.e7. \n                    https:\/\/doi.org\/10.1016\/j.exphem.2011.07.008\n                    \n                  .","journal-title":"Exp Hematol"},{"key":"4993_CR20","doi-asserted-by":"publisher","first-page":"5316","DOI":"10.1182\/blood-2010-05-285395","volume":"116","author":"G Ramsingh","year":"2010","unstructured":"Ramsingh G, Koboldt DC, Trissal M, Chiappinelli KB, Wylie T, Koul S, et al. Complete characterization of the microRNAome in a patient with acute myeloid leukemia. Blood. 2010;116:5316\u201326. \n                    https:\/\/doi.org\/10.1182\/blood-2010-05-285395\n                    \n                  .","journal-title":"Blood"},{"key":"4993_CR21","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1158\/0008-5472.CAN-06-2698","volume":"67","author":"A Gaur","year":"2007","unstructured":"Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen C, et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res. 2007;67:2456\u201368. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-2698\n                    \n                  .","journal-title":"Cancer Res"},{"key":"4993_CR22","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/hep.22158","volume":"47","author":"H Varnholt","year":"2008","unstructured":"Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, Dienes H-P, et al. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatol Baltim Md. 2008;47:1223\u201332. \n                    https:\/\/doi.org\/10.1002\/hep.22158\n                    \n                  .","journal-title":"Hepatol Baltim Md"},{"key":"4993_CR23","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.297.17.1901","volume":"297","author":"M Bloomston","year":"2007","unstructured":"Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA. 2007;297:1901\u20138. \n                    https:\/\/doi.org\/10.1001\/jama.297.17.1901\n                    \n                  .","journal-title":"JAMA"},{"key":"4993_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/cdd.2009.58","volume":"17","author":"AH Lund","year":"2010","unstructured":"Lund AH. miR-10 in development and cancer. Cell Death Differ. 2010;17:209\u201314. \n                    https:\/\/doi.org\/10.1038\/cdd.2009.58\n                    \n                  .","journal-title":"Cell Death Differ"},{"key":"4993_CR25","doi-asserted-by":"publisher","first-page":"10924","DOI":"10.1038\/ncomms10924","volume":"7","author":"J Koya","year":"2016","unstructured":"Koya J, Kataoka K, Sato T, Bando M, Kato Y, Tsuruta-Kishino T, et al. DNMT3A R882 mutants interact with polycomb proteins to block haematopoietic stem and leukaemic cell differentiation. Nat Commun. 2016;7:10924. \n                    https:\/\/doi.org\/10.1038\/ncomms10924\n                    \n                  .","journal-title":"Nat Commun"},{"key":"4993_CR26","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1089\/scd.2008.0227","volume":"18","author":"M Iacovino","year":"2009","unstructured":"Iacovino M, Hernandez C, Xu Z, Bajwa G, Prather M, Kyba M. A conserved role for Hox paralog group 4 in regulation of hematopoietic progenitors. Stem Cells Dev. 2009;18:783\u201392. \n                    https:\/\/doi.org\/10.1089\/scd.2008.0227\n                    \n                  .","journal-title":"Stem Cells Dev"},{"key":"4993_CR27","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/sj.leu.2401410","volume":"13","author":"H Kawagoe","year":"1999","unstructured":"Kawagoe H, Humphries RK, Blair A, Sutherland HJ, Hogge DE. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells. Leukemia. 1999;13:687\u201398.","journal-title":"Leukemia"},{"key":"4993_CR28","doi-asserted-by":"publisher","first-page":"16952","DOI":"10.1073\/pnas.0703082104","volume":"104","author":"B Schiedlmeier","year":"2007","unstructured":"Schiedlmeier B, Santos AC, Ribeiro A, Moncaut N, Lesinski D, Auer H, et al. HOXB4\u2019s road map to stem cell expansion. Proc Natl Acad Sci U S A. 2007;104:16952\u20137. \n                    https:\/\/doi.org\/10.1073\/pnas.0703082104\n                    \n                  .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4993_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrc1840","volume":"6","author":"A Esquela-Kerscher","year":"2006","unstructured":"Esquela-Kerscher A, Slack FJ. Oncomirs \u2014 microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259\u201369. \n                    https:\/\/doi.org\/10.1038\/nrc1840\n                    \n                  .","journal-title":"Nat Rev Cancer"},{"key":"4993_CR30","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1056\/NEJMoa1005143","volume":"363","author":"TJ Ley","year":"2010","unstructured":"Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE, et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med. 2010;363:2424\u201333. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1005143\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"4993_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/ng.788","volume":"43","author":"X-J Yan","year":"2011","unstructured":"Yan X-J, Xu J, Gu Z-H, Pan C-M, Lu G, Shen Y, et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet. 2011;43:309\u201315. \n                    https:\/\/doi.org\/10.1038\/ng.788\n                    \n                  .","journal-title":"Nat Genet"},{"key":"4993_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1476-4598-11-8","volume":"11","author":"A Bryant","year":"2012","unstructured":"Bryant A, Palma CA, Jayaswal V, Yang YW, Lutherborrow M, Ma DD. miR-10a is aberrantly overexpressed in Nucleophosmin1 mutated acute myeloid leukaemia and its suppression induces cell death. Mol Cancer. 2012;11:8. \n                    https:\/\/doi.org\/10.1186\/1476-4598-11-8\n                    \n                  .","journal-title":"Mol Cancer"},{"key":"4993_CR33","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1200\/JCO.2014.59.2022","volume":"33","author":"RE Gale","year":"2015","unstructured":"Gale RE, Lamb K, Allen C, El-Sharkawi D, Stowe C, Jenkinson S, et al. Simpson\u2019s paradox and the impact of different DNMT3A mutations on outcome in younger adults with acute myeloid leukemia. J Clin Oncol Off J Am Soc Clin Oncol. 2015;33:2072\u201383. \n                    https:\/\/doi.org\/10.1200\/JCO.2014.59.2022\n                    \n                  .","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"4993_CR34","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/leu.2011.238","volume":"26","author":"E Tiacci","year":"2012","unstructured":"Tiacci E, Spanhol-Rosseto A, Martelli MP, Pasqualucci L, Quentmeier H, Grossmann V, et al. The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations. Leukemia. 2012;26:554\u20137. \n                    https:\/\/doi.org\/10.1038\/leu.2011.238\n                    \n                  .","journal-title":"Leukemia"},{"key":"4993_CR35","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1073\/pnas.0610983104","volume":"104","author":"RW Georgantas","year":"2007","unstructured":"Georgantas RW, Hildreth R, Morisot S, Alder J, Liu C-G, Heimfeld S, et al. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci. 2007;104:2750\u20135. \n                    https:\/\/doi.org\/10.1073\/pnas.0610983104\n                    \n                  .","journal-title":"Proc Natl Acad Sci"},{"key":"4993_CR36","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1182\/blood-2013-10-532374","volume":"123","author":"V Havelange","year":"2014","unstructured":"Havelange V, Ranganathan P, Geyer S, Nicolet D, Huang X, Yu X, et al. Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML. Blood. 2014;123:2412\u20135. \n                    https:\/\/doi.org\/10.1182\/blood-2013-10-532374\n                    \n                  .","journal-title":"Blood"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4993-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4993-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4993-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T19:09:54Z","timestamp":1573499394000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4993-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,12]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4993"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4993-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,12]]},"assertion":[{"value":"4 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent was obtained from all patients in accordance with the Declaration of Helsinki, allowing the collection of clinical and biological data in an anonymized database, registered at the Commission Nationale de l\u2019Informatique et des Libert\u00e9s under N\u00b01777604. Experiments on mice were performed in conformity with the rules of the Institutional Animal Care and Use committee (Ministerial approval number 00048.2).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1098"}}